Literature DB >> 32281722

Potential role of insulin on the pathogenesis of depression.

Xiao Han Zou1, Li Hua Sun1, Wei Yang1, Bing Jin Li1, Ran Ji Cui1.   

Abstract

The regulation of insulin on depression and depression-like behaviour has been widely reported. Insulin and activation of its receptor can promote learning and memory, affect the hypothalamic-pituitary-adrenal axis (HPA) balance, regulate the secretion of neurotrophic factors and neurotransmitters, interact with gastrointestinal microbiome, exert neuroprotective effects and have an impact on depression. However, the role of insulin on depression remains largely unclear. Therefore, in this review, we summarized the potential role of insulin on depression. It may provide new insight for clarifying role of insulin on the pathogenesis of depression.
© 2020 The Authors. Cell Proliferation Published by John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 32281722     DOI: 10.1111/cpr.12806

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  9 in total

Review 1.  The Therapeutic Role of Ketogenic Diet in Neurological Disorders.

Authors:  Diana Pietrzak; Kamila Kasperek; Paweł Rękawek; Iwona Piątkowska-Chmiel
Journal:  Nutrients       Date:  2022-05-06       Impact factor: 6.706

Review 2.  Insulin action in the brain regulates both central and peripheral functions.

Authors:  Rahul Agrawal; Candace M Reno; Sunny Sharma; Camille Christensen; Yiqing Huang; Simon J Fisher
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-05-31       Impact factor: 5.900

3.  Low levels of soluble TWEAK, indicating on-going inflammation, were associated with depression in type 1 diabetes: a cross-sectional study.

Authors:  Eva O Melin; Jonatan Dereke; Magnus Hillman
Journal:  BMC Psychiatry       Date:  2020-12-01       Impact factor: 3.630

4.  Potential Genes and Mechanisms Linking Intracerebral Hemorrhage and Depression: A Bioinformatics-Based Study.

Authors:  Cuihua Zou; Xiaohua Huang; Xuequn Lan; Xiaorui Huang; Yun Feng; Jianmin Huang; Lanqing Meng; Chongdong Jian; Donghua Zou; Jie Wang; Xuebin Li
Journal:  Int J Gen Med       Date:  2021-04-07

Review 5.  Another Example of Conditioned Taste Aversion: Case of Snails.

Authors:  Junko Nakai; Yuki Totani; Dai Hatakeyama; Varvara E Dyakonova; Etsuro Ito
Journal:  Biology (Basel)       Date:  2020-11-26

6.  The relationship between health-related quality of life and melancholic depressive symptoms is modified by brain insulin receptor gene network.

Authors:  Jannica S Selenius; Patricia P Silveira; Minna Salonen; Hannu Kautiainen; Mikaela von Bonsdorff; Eero Kajantie; Jari Lahti; Johan G Eriksson; Niko S Wasenius
Journal:  Sci Rep       Date:  2021-11-03       Impact factor: 4.379

7.  High-Protein, Low-Glycaemic Meal Replacement Improves Physical Health-Related Quality of Life in High-Risk Persons for Metabolic Syndrome-A Subanalysis of the Randomised-Controlled ACOORH Trial.

Authors:  Kerstin Kempf; Martin Röhling; Winfried Banzer; Klaus Michael Braumann; Martin Halle; Nina Schaller; David McCarthy; Hans Georg Predel; Isabelle Schenkenberger; Susanne Tan; Hermann Toplak; Stephan Martin; Aloys Berg
Journal:  Nutrients       Date:  2022-07-30       Impact factor: 6.706

8.  High Fructose Corn Syrup-Moderate Fat Diet Potentiates Anxio-Depressive Behavior and Alters Ventral Striatal Neuronal Signaling.

Authors:  Ayanabha Chakraborti; Christopher Graham; Sophie Chehade; Bijal Vashi; Alan Umfress; Pradeep Kurup; Benjamin Vickers; H Alexander Chen; Rahul Telange; Taylor Berryhill; William Van Der Pol; Mickie Powell; Stephen Barnes; Casey Morrow; Daniel L Smith; M Shahid Mukhtar; Stephen Watts; Gregory Kennedy; James Bibb
Journal:  Front Neurosci       Date:  2021-05-26       Impact factor: 4.677

Review 9.  Clinical Evidence of Antidepressant Effects of Insulin and Anti-Hyperglycemic Agents and Implications for the Pathophysiology of Depression-A Literature Review.

Authors:  Young Sup Woo; Hyun Kook Lim; Sheng-Min Wang; Won-Myong Bahk
Journal:  Int J Mol Sci       Date:  2020-09-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.